Lipocine (LPCN) news

Orsl unit wins BPCL EPCOM pact for CBG plant in Hubli

Oriana Power Limited has secured a contract to provide engineering, procurement, and construction (EPC) services for a compressed biogas (CBG) plant in Hubli, India. The project is part of a broader national initiative to expand domestic CBG production and reduce reliance on imported natural gas.…

Lipocine - Verity Pharma to launch Tlando in Canada by end of 2026 - SEC filing

Lipocine Inc. (NASDAQ:LPCN) has announced plans to launch its testosterone therapy product, Tlando, in Canada by the end of 2026, according to a recent SEC filing. The company has partnered with Verity Pharma for the commercialization of the product in the Canadian market. Tlando, a novel oral…

Lipocine - Health Canada approves Tlando for testosterone replacement therapy in adult males - SEC filing

Lipocine Inc. (NASDAQ: LPCN) has announced that Health Canada has approved TLANDO (testosterone undecanoate) for testosterone replacement therapy in adult males with conditions associated with a deficiency of endogenous testosterone, also known as hypogonadism approval . TLANDO, a novel oral…

Lipocine - Bloom study plans to enroll about 120 participants with severe postpartum depression

Lipocine Inc. (NASDAQ: LPCN) has announced plans for the "Bloom" study, a clinical trial aiming to enroll approximately 120 participants with severe postpartum depression (PPD) to further evaluate the potential of its drug candidate, LPCN 1154. The study will build on recent Phase 3 trial results,…

Lipocine - First participant dosing in Bloom study expected in early Q4 2026